Literature DB >> 28041910

Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis - Case report.

Diana Rosa-Gonçalves1, Miguel Bernardes2, Lúcia Costa2.   

Abstract

We present a case of necrotizing fasciitis in a 66-year-old Caucasian woman with rheumatoid arthritis receiving tocilizumab, and provide a review of published cases. The patient exhibited no systemic symptoms and discreet cutaneous inflammatory signals at presentation. She was successfully treated with broad-spectrum empiric antibiotic therapy and surgical debridement.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  Antagonistas del factor de necrosis tumoral alfa; Artritis reumatoide; Fascitis necrosante; Infección; Infection; Necrotizing fasciitis; Piel; Rheumatoid arthritis; Skin; Tocilizumab; Tumor necrosis factor antagonists

Mesh：

Substances：

Year:  2016        PMID： 28041910     DOI： 10.1016/j.reuma.2016.10.008

Source DB:  PubMed          Journal:  Reumatol Clin (Engl Ed)        ISSN： 2173-5743


  4 in total

1.  Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab

Authors:  Kazuya Goto; Toshiaki Kogame; Nobuhiro Kusuba; Yuichiro Endo; Teruki Dainichi; Kenji Kabashima
Journal:  Eur J Dermatol       Date:  2022-04-01       Impact factor: 2.805

2.  Opportunistic Invasive Infection by Group A Streptococcus During Anti-Interleukin-6 Immunotherapy.

Authors:  Shyra Wilde; Katherine L Olivares; Victor Nizet; Hal M Hoffman; Suhas Radhakrishna; Christopher N LaRock
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

Review 3.  Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.

Authors:  Antonio Martinez-Lopez; Carlos Cuenca-Barrales; Trinidad Montero-Vilchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Am Acad Dermatol       Date:  2020-08-07       Impact factor: 11.527

4.  The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature.

Authors:  Mark Berman; Ronen Ben-Ami; Shlomo Berliner; Marina Anouk; Ilana Kaufman; Adi Broyde; Sara Borok; Ori Elkayam
Journal:  Life (Basel)       Date:  2021-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.